UK MHRA Says Genetic Biobank Could Transform Drug Safety Monitoring Through Personalized Medicine
Executive Summary
The biobank, which the UK regulator believes puts it at the forefront of innovation in the field of drug safety monitoring, will enter a pilot in June, starting with the gout treatment allopurinol and related rare, severe skin reactions.